ADH2 Stock Overview
Provides domestic, U.S. transborder, and international airline services.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Air Canada Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$12.11 |
| 52 Week High | CA$17.56 |
| 52 Week Low | CA$10.92 |
| Beta | 2.48 |
| 11 Month Change | 0.33% |
| 3 Month Change | -8.76% |
| 1 Year Change | -29.29% |
| 33 Year Change | -29.88% |
| 5 Year Change | n/a |
| Change since IPO | -12.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| ADH2 | DE Airlines | DE Market | |
|---|---|---|---|
| 7D | 5.4% | -2.0% | 0.09% |
| 1Y | -29.3% | -26.8% | 3.1% |
Return vs Industry: ADH2 underperformed the German Airlines industry which returned -26.8% over the past year.
Return vs Market: ADH2 underperformed the German Market which returned 3.1% over the past year.
Price Volatility
| ADH2 volatility | |
|---|---|
| ADH2 Average Weekly Movement | 4.1% |
| Airlines Industry Average Movement | 4.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: ADH2 has not had significant price volatility in the past 3 months.
Volatility Over Time: ADH2's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 36,900 | Mike Rousseau | www.aircanada.com |
Air Canada provides domestic, U.S. transborder, and international airline services. The company provides scheduled passenger services under the Air Canada Vacations and Air Canada Rouge brand names in the Canadian market, the Canada-U.S. transborder market, and in the international market to and from Canada, as well as through capacity purchase agreements on other regional carriers.
Air Canada Fundamentals Summary
| ADH2 fundamental statistics | |
|---|---|
| Market cap | €4.38b |
| Earnings (TTM) | €1.49b |
| Revenue (TTM) | €15.13b |
2.9x
P/E Ratio0.3x
P/S RatioIs ADH2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ADH2 income statement (TTM) | |
|---|---|
| Revenue | CA$22.17b |
| Cost of Revenue | CA$14.75b |
| Gross Profit | CA$7.42b |
| Other Expenses | CA$5.23b |
| Earnings | CA$2.19b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.11 |
| Gross Margin | 33.48% |
| Net Profit Margin | 9.88% |
| Debt/Equity Ratio | 1,416.9% |
How did ADH2 perform over the long term?
See historical performance and comparison